Roche’s Phase III persevERA Trial of Giredestrant Misses Primary Endpoint in Advanced ER-Positive Breast Cancer
- March 13, 2026
BASELINE
Daiichi Sankyo Advances Enhertu for High-Risk Breast Cancer: New Hope After Neoadjuvant Therapy
FDA Approves BMS’s Sotyktu for Psoriatic Arthritis
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
It's Endometriosis Awareness Month! Over 200 million women worldwide live with endometriosis, yet many go undiagnosed for years. Swipe to understand what this condition is, what symptoms look like, and what the risk factors are. #endometriosisawarenessmonth #endometriosis #endowarriors #youarenotalone #PatientWorthy
International Rett Syndrome FoundationHope matters. Action matters more.
In Rett Research in Motion: IRSF’s 2026 State of Research, Dr. Dominique Pichard and the IRSF scientific team gave an update on clinical trials and explained why progress in Rett syndrome depends on pursuing both genetic and non-genetic treatment approaches — building a pipeline of therapies that can work together to improve outcomes.
Missed it live? Watch the full webinar recording:
🎥 youtu.be/HRqav2LwkxI
